TY - JOUR
T1 - Macrophage scavenger receptor a promotes tumor progression in murine models of ovarian and pancreatic cancer
AU - Neyen, Claudine
AU - Plüddemann, Annette
AU - Mukhopadhyay, Subhankar
AU - Maniati, Eleni
AU - Bossard, Maud
AU - Gordon, Siamon
AU - Hagemann, Thorsten
PY - 2013/4/1
Y1 - 2013/4/1
N2 - Alternatively activated macrophages express the pattern recognition receptor scavenger receptor A (SR-A).We demonstrated previously that coculture of macrophages with tumor cells upregulates macrophage SR-A expression.We show in this study that macrophage SR-A deficiency inhibits tumor cell migration in a coculture assay. We further demonstrate that coculture of tumorassociated macrophages and tumor cells induces secretion of factors that are recognized by SR-A on tumor-associated macrophages. We tentatively identified several potential ligands for the SR-A receptor in tumor cell-macrophage cocultures by mass spectrometry. Competing with the coculture-induced ligand in our invasion assay recapitulates SR-A deficiency and leads to similar inhibition of tumor cell invasion. In line with our in vitro findings, tumor progression and metastasis are inhibited in SR-A-/- mice in two in vivo models of ovarian and pancreatic cancer. Finally, treatment of tumor-bearing mice with 4F, a small peptide SR-A ligand able to compete with physiological SR-A ligands in vitro, recapitulates the inhibition of tumor progression and metastasis observed in SR-A-/- mice. Our observations suggest that SR-A may be a potential drug target in the prevention of metastatic cancer progression.
AB - Alternatively activated macrophages express the pattern recognition receptor scavenger receptor A (SR-A).We demonstrated previously that coculture of macrophages with tumor cells upregulates macrophage SR-A expression.We show in this study that macrophage SR-A deficiency inhibits tumor cell migration in a coculture assay. We further demonstrate that coculture of tumorassociated macrophages and tumor cells induces secretion of factors that are recognized by SR-A on tumor-associated macrophages. We tentatively identified several potential ligands for the SR-A receptor in tumor cell-macrophage cocultures by mass spectrometry. Competing with the coculture-induced ligand in our invasion assay recapitulates SR-A deficiency and leads to similar inhibition of tumor cell invasion. In line with our in vitro findings, tumor progression and metastasis are inhibited in SR-A-/- mice in two in vivo models of ovarian and pancreatic cancer. Finally, treatment of tumor-bearing mice with 4F, a small peptide SR-A ligand able to compete with physiological SR-A ligands in vitro, recapitulates the inhibition of tumor progression and metastasis observed in SR-A-/- mice. Our observations suggest that SR-A may be a potential drug target in the prevention of metastatic cancer progression.
UR - https://www.scopus.com/pages/publications/84875455428
U2 - 10.4049/jimmunol.1203194
DO - 10.4049/jimmunol.1203194
M3 - 文章
C2 - 23447685
AN - SCOPUS:84875455428
SN - 0022-1767
VL - 190
SP - 3798
EP - 3805
JO - Journal of Immunology
JF - Journal of Immunology
IS - 7
ER -